What is Edward G. Rendell’s total NHP share ownership after this Form 4 transaction?

After the reported award, Edward G. Rendell directly holds 24,075 shares of National Healthcare Properties common stock. This total includes the 12,500 newly granted restricted shares that will vest over four years, assuming he satisfies the continued service requirements.

Edward G. Rendell receives 12,500 NHP (NHP) restricted shares vesting over 4 years

Q: How do the new restricted shares for NHP director Edward G. Rendell vest?

The 12,500 restricted shares of NHP common stock vest in four equal 25% installments. Vesting occurs on each of the first four anniversaries of the April 30, 2026 grant date, and is conditioned on his continued service through each applicable vesting date.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Rendell Edward G reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Properties, Inc. director Edward G. Rendell received a grant of 12,500 shares of restricted common stock on April 30, 2026. The award was issued at no cash cost to him under the company’s 2025 Omnibus Incentive Compensation Plan.

The restricted shares will vest in 25% increments on each of the first four anniversaries of the grant date, as long as he continues to serve through each vesting date. Following this grant, Rendell directly holds 24,075 shares of National Healthcare Properties common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rendell Edward G

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	12,500	$0.00	--

Holdings After Transaction: Common Stock — 24,075 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Restricted shares granted: 12,500 shares Post-transaction holdings: 24,075 shares Grant price per share: $0.0000 per share +2 more

5 metrics

Restricted shares granted 12,500 shares Common Stock award on April 30, 2026

Post-transaction holdings 24,075 shares Total common stock held directly after grant

Grant price per share $0.0000 per share Reported transaction price for restricted stock grant

Par value per share $0.01 per share Par value of National Healthcare Properties common stock

Vesting schedule 25% per year over 4 years Annual vesting on each of first four anniversaries of April 30, 2026

Key Terms

restricted shares, 2025 Omnibus Incentive Compensation Plan, par value $0.01 per share, vesting

4 terms

restricted shares financial

"Represents restricted shares of National Healthcare Properties, Inc.'s common stock"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

2025 Omnibus Incentive Compensation Plan financial

"issued under NHP's 2025 Omnibus Incentive Compensation Plan that will vest"

vesting financial

"will vest in 25% increments on each of the first four anniversaries"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 08:43 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rendell Edward G

(Last)

(First)

(Middle)

C/O NATIONAL HEALTHCARE PROPERTIES, INC.

540 MADISON AVE., 27TH FLOOR

(Street)

NEW YORK

10022

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
National Healthcare Properties, Inc. [ NHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/30/2026		A		12,500⁽¹⁾	A	$0⁽¹⁾	24,075	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents restricted shares of National Healthcare Properties, Inc.'s ("NHP") common stock, par value $0.01 per share ("Common Stock"), issued under NHP's 2025 Omnibus Incentive Compensation Plan that will vest in 25% increments on each of the first four anniversaries of the April 30, 2026 grant date, subject to the recipient's continued service through the applicable vesting date.

Remarks:

	/s/ Jie Chai, Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Edward G. Rendell report in his Form 4 for NHP?

Edward G. Rendell reported receiving 12,500 restricted shares of National Healthcare Properties, Inc. common stock. The award was granted at no cash cost under the company’s 2025 Omnibus Incentive Compensation Plan and increases his direct holdings to 24,075 shares after the transaction.

How do the new restricted shares for NHP director Edward G. Rendell vest?

The 12,500 restricted shares of NHP common stock vest in four equal 25% installments. Vesting occurs on each of the first four anniversaries of the April 30, 2026 grant date, and is conditioned on his continued service through each applicable vesting date.

Was cash paid for the 12,500 NHP restricted shares granted to Edward G. Rendell?

No cash was paid for the award. The 12,500 restricted shares of NHP common stock were granted at a reported price of $0.0000 per share as compensation under the 2025 Omnibus Incentive Compensation Plan rather than through an open-market purchase.

Under which plan were Edward G. Rendell’s new NHP restricted shares granted?

The 12,500 restricted shares of National Healthcare Properties common stock were issued under the company’s 2025 Omnibus Incentive Compensation Plan. This plan provides equity-based compensation, and these particular shares vest over four years subject to continued service conditions.